Drug approval in the healthcare markets EU vs. US

Drug approval in the healthcare markets EU vs. US

Continue reading →

Drugs affordability vs R&D development

Drugs affordability vs R&D development

Continue reading →

Healthcare’s digital revolution and FIT

Healthcare’s digital revolution and FIT

Continue reading →

The Hidden Costs of Covid-19

The Hidden Costs of Covid-19

Elective care surgeries since Covid-19 have been cancelled globally. The 45-week backlog for elective procedures that arose in May 2020 lingers. A recent study by CovidSurg Collaborative researchers collected data from 359 hospitals across 71 countries. The study showed...

Continue reading →

Horseshoe crab blood is key to making a Covid-19 vaccine – but the ecosystem may suffer

Horseshoe crab blood is key to making a Covid-19 vaccine – but the ecosystem may suffer

In 2016 a synthetic alternative (rFC) to horseshoe crab blood, used in bacterial infection detection for injectable procedures, was licensed. And yet horseshoe crabs are both threatened with extinction and in line for preservation due to Covid-19 and its...

Continue reading →

How will the rise of biosimilars impact biologics

How will the rise of biosimilars impact biologics

● Once patents expire for biologic medicines, a market opportunity opens up for biosimilars, a cheaper alternative. Biosimilars were mainly brought in to thwart the monopoly power of biologics in the pharmaceutical industry. ● Biosimilars are expected to increase at...

Continue reading →

Doctors may be missing illnesses because UK medical textbooks often focus on white people

Doctors may be missing illnesses because UK medical textbooks often focus on white people

Malone Mukwende, a medical student from St. George's, University of London noticed during his studies that there was a problem with Ethnic Dermatology. Mr Mukwende's observation leads us to wider questions over healthcare investment opportunities, telemedicine, remote patient monitoring,...

Continue reading →

Hospital margins are down – is selling your health data a solution

Hospital margins are down – is selling your health data a solution

A framework allowing a more sensible approach to health data collection In our previous blog we outlined the pressure on hospital margins and the entire hospital business model as a direct result of Covid-19. One solution is the sale by...

Continue reading →

Why are drug prices rising faster than inflation?

Why are drug prices rising faster than inflation?

Drug makers typically raise prices at the beginning of the year and this year is no different. Prices on 457 brand name drugs are due to increase this year by an average of 5.1%. (GoodRx). About 102 drug manufacturers,...

Continue reading →